Recent Updates
Recently added Catalysts
IMRX Positive Sentiment

Frank Wang, Ph.D.

Key Takeaway: Dr. Frank Wang, Ph.D., has extensive experience in computational biology, focusing on human diseases. He earned his Ph.D. in Bioinformatics and has worked on identifying biomarkers for breast cancer and systemic sclerosis. His research includes drug repositioning and classification of patient subsets, utilizing various biological data types.
Price reaction · baseline $6.73 (2025-12-26 close) · 16 other IMRX headline(s) in the window, move may be shared
day 0 close · peak
-1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Dr. Wang has over 8 years of experience in computational biology.
  • He has a strong academic background with a Ph.D. in Bioinformatics.
  • His research focuses on significant areas like breast cancer and systemic sclerosis.
  • He has expertise in various advanced computational techniques.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+41%
120-day peak, hindsight
Typical move
11.4%
average across 8 past catalysts
Cash runway
~36 mo
Minimal dilution risk
Lead asset
IMM-1-104 Monotherapy
Phase 1 · Advanced Solid Tumor

Full Press Release Details

Dr. Wang has been working on integrating computational approaches and biological data to investigate the biology underlying human diseases for over 8 years. He earned his Ph.D. in Bioinformatics from Department of Information and Communication Engineering, Huazhong University of Science and Technology, China. During his Ph.D. career, he spent two years in Genetics at Dartmouth College as a visiting scholar. His major research focus was computationally identifying novel biomarkers for predicting survival outcomes in breast cancer. During his postdoctoral research in the Department of Biomedical Data Science at Geisel School of Medicine at Dartmouth he worked on drug repositioning, novel biomarkers identification, and patients ‘intrinsic’ subsets classification in Systemic Sclerosis (SSc, a rare autoimmune disease) in the Whitfield lab. Frank then became a research scientist in the same lab and continued his computational research in SSc. He has interest and expertise in performing computational analyses in different biological data types including microarray, DNA methylation, ChIP-seq, single-cell/bulk RNA-seq, and ATAC-seq data.

Frequently Asked Questions

What is Dr. Frank Wang's research focus?

Dr. Wang focuses on identifying biomarkers for predicting survival outcomes in breast cancer.

Where did Dr. Wang earn his Ph.D.?

He earned his Ph.D. in Bioinformatics from Huazhong University of Science and Technology, China.

What experience does Dr. Wang have in autoimmune diseases?

He worked on systemic sclerosis during his postdoctoral research at Dartmouth.

What types of biological data does Dr. Wang analyze?

He analyzes microarray, DNA methylation, RNA-seq, and ATAC-seq data.

Last updated: Dec 27, 2025